Danaher | DHR - Eigenkapital Und Reserven

Aktienkurs
194.45
Täglich Wechseln
-1.05 -0.54%
Monatlich
2.34%
Jährlich
1.24%
Q2 Prognose
190.47




Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.13B 1.3B 2025-12
Agilent USD 6.91B 167M 2025-12
Align Technology USD 3.96B 44.68M 2025-09
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Bio Techne USD 2.01B 45.18M 2025-12
Bio-Rad Laboratories USD 7.45B 716.8M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Bruker USD 2.49B 625.6M 2025-09
Charles River Laboratories USD 3.16B 240.82M 2025-12
Danaher USD 52.95B 415M 2026-03
Dentsply International USD 1.34B 139M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
ESCO Technologies USD 1.56B 19.99M 2025-12
Fortive USD 6.45B 50.5M 2025-12
Henry Schein USD 3.24B 116M 2025-12
Illumina USD 2.72B 342M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
Keysight Technologies USD 6.2B 328M 2025-12
Laboratory Of America USD 8.62B 93.2M 2025-12
Medtronic USD 48.99B 128M 2025-12
Mettler Toledo International USD -23.64M 225.56M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
OraSure Technologies USD 340.83M 21.15M 2025-12
Quest Diagnostics USD 7.37B 196M 2026-03
Quidel USD 1.92B 115.9M 2025-12
Repligen USD 2.11B 1.66B 2025-12
Revvity USD 7.38B 180.27M 2025-09
Roper Industries USD 19.88B 111.3M 2025-12
Stryker USD 21.78B 594M 2025-09
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Waters USD 2.56B 230.55M 2025-12
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12